PC
PenderFund Capital Management Ltd.
13F filer · CIK 0001706164Reported Aug 17, 2026
Net seller this quarter
13F portfolio value$780MU.S. long equity reported on 13F
Positions20562 new · 82 closed
Net flow last quarter-$3.61MBuys minus sells
Top 10 positions weight15.1%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 17, 2026205 positions | |||||
| $16.7M | 2.14% | 13.19% | +55.5% | Q4 2021 | |
| $15.3M | 1.97% | Not reported | Not reported | Q3 2025 | |
| $14.2M | 1.81% | 1.96% | Not reported | Q2 2019 | |
| $13.5M | 1.73% | Not reported | Not reported | Q1 2026 | |
| ETESPREsperion Therapeutics, Inc. | $12.3M | 1.57% | 1.51% | -0.2% | Q1 2025 |
| $11.3M | 1.45% | 0.64% | -50.0% | Q1 2024 | |
| $11M | 1.41% | Not reported | -39.3% | Q2 2025 | |
| $8.39M | 1.08% | Not reported | -2.4% | Q1 2019 | |
| $7.59M | 0.97% | Not reported | -57.9% | Q1 2026 | |
| $7.46M | 0.96% | Not reported | +108.1% | Q1 2026 | |
| $2.97M | 0.38% | Not reported | +26.2% | Q2 2022 | |
| $2.76M | 0.35% | 0.45% | Not reported | Q1 2026 | |
| $2.65M | 0.34% | 0.02% | +0.1% | Q4 2025 | |
| $2.45M | 0.31% | 0.02% | +0.9% | Q4 2025 | |
| $2.44M | 0.31% | Not reported | Not reported | Q1 2026 | |
| $2.44M | 0.31% | 0.00% | -9.5% | Q1 2019 | |
| $2.39M | 0.31% | 0.18% | Not reported | Q3 2025 | |
| $2.38M | 0.30% | 0.03% | +0.5% | Q1 2020 | |
| $2.34M | 0.30% | 0.00% | New | Q2 2026 | |
| $2.25M | 0.29% | 0.01% | +0.6% | Q3 2024 | |
| $2.22M | 0.28% | 0.01% | -30.2% | Q1 2026 | |
| $1.92M | 0.25% | 0.01% | -8.0% | Q2 2025 | |
| $1.86M | 0.24% | 0.10% | +0.1% | Q2 2025 | |
| $1.84M | 0.24% | 0.03% | -25.3% | Q1 2022 | |
| $1.79M | 0.23% | 0.13% | -25.4% | Q1 2024 | |
| $1.7M | 0.22% | Not reported | +57.2% | Q1 2025 | |
| $1.45M | 0.19% | 0.00% | +69.6% | Q1 2020 | |
| $1.45M | 0.19% | 0.00% | New | Q2 2026 | |
| $1.4M | 0.18% | 0.01% | +0.2% | Q3 2025 | |
| $1.39M | 0.18% | 0.25% | -4.1% | Q2 2025 | |
| $1.34M | 0.17% | Not reported | +26.3% | Q3 2025 | |
| $1.28M | 0.16% | 0.00% | -12.5% | Q1 2026 | |
| $1.28M | 0.16% | Not reported | Not reported | Q2 2022 | |
| $1.25M | 0.16% | Not reported | -17.7% | Q4 2022 | |
| $1.24M | 0.16% | 0.00% | New | Q2 2026 | |
| $1.19M | 0.15% | 0.19% | +51.9% | Q4 2025 | |
| $1.13M | 0.15% | 0.00% | New | Q2 2026 | |
| CIGTLSChart Industries Inc | $1.13M | 0.14% | 0.01% | +74.2% | Q3 2025 |
| $1.11M | 0.14% | 0.00% | New | Q2 2026 | |
| $1.09M | 0.14% | 0.04% | +88.5% | Q3 2025 | |
| $1.07M | 0.14% | 0.01% | +0.4% | Q4 2025 | |
| $1.04M | 0.13% | 0.01% | Not reported | Q3 2025 | |
| $992K | 0.13% | 0.00% | Not reported | Q3 2025 | |
| $987K | 0.13% | 0.00% | Not reported | Q1 2026 | |
| $972K | 0.12% | 0.03% | New | Q2 2026 | |
| $958K | 0.12% | 0.00% | Not reported | Q1 2026 | |
| $913K | 0.12% | 0.01% | -29.3% | Q3 2024 | |
| $900K | 0.12% | 0.20% | +115.7% | Q3 2025 | |
| $843K | 0.11% | Not reported | Not reported | Q1 2022 | |
| $822K | 0.11% | 0.00% | -18.6% | Q4 2024 | |
| Q1 2026Reported May 15, 2026225 positions | |||||
| $28.5M | 4.47% | 1.16% | -33.9% | Q1 2024 | |
| $14.8M | 2.32% | Not reported | New | Q1 2026 | |
| $13.1M | 2.06% | Not reported | -9.4% | Q2 2025 | |
| $11.7M | 1.84% | 0.10% | Not reported | Q3 2025 | |
| $11.1M | 1.74% | 8.48% | 0.0% | Q4 2021 | |
| $11.1M | 1.73% | Not reported | New | Q1 2026 | |
| $10.8M | 1.70% | 1.97% | Not reported | Q2 2019 | |
| ETESPREsperion Therapeutics, Inc. | $10.7M | 1.67% | 1.52% | -11.4% | Q1 2025 |
| $8.66M | 1.36% | Not reported | +0.8% | Q1 2019 | |
| $3.76M | 0.59% | 0.18% | Not reported | Q3 2025 | |
| $3.66M | 0.57% | Not reported | New | Q1 2026 | |
| $3.44M | 0.54% | 0.45% | New | Q1 2026 | |
| $3.05M | 0.48% | 0.04% | +2.4% | Q1 2022 | |
| $2.82M | 0.44% | 0.17% | +113.7% | Q1 2024 | |
| $2.71M | 0.43% | 0.00% | +48.6% | Q1 2019 | |
| $2.44M | 0.38% | Not reported | New | Q1 2026 | |
| $2.25M | 0.35% | 0.23% | Not reported | Q4 2020 | |
| $2.12M | 0.33% | 0.02% | New | Q1 2026 | |
| $2.11M | 0.33% | 0.03% | Not reported | Q1 2020 | |
| $2.1M | 0.33% | 0.02% | +894.4% | Q2 2025 | |
| $2.1M | 0.33% | 0.02% | +0.7% | Q4 2025 | |
| $2.1M | 0.33% | 0.02% | +9314.3% | Q4 2025 | |
| $2.03M | 0.32% | 0.01% | Not reported | Q3 2024 | |
| $2.03M | 0.32% | Not reported | Not reported | Q2 2022 | |
| $1.73M | 0.27% | 0.10% | +0.4% | Q2 2025 | |
| $1.54M | 0.24% | 0.26% | +30.1% | Q2 2025 | |
| $1.52M | 0.24% | 0.00% | New | Q1 2026 | |
| $1.44M | 0.23% | Not reported | -22.8% | Q4 2022 | |
| $1.41M | 0.22% | Not reported | Not reported | Q1 2025 | |
| $1.37M | 0.22% | 0.01% | +4934.3% | Q4 2025 | |
| $1.28M | 0.20% | 0.01% | -48.5% | Q3 2025 | |
| $1.06M | 0.17% | 0.00% | Not reported | Q3 2025 | |
| $1.04M | 0.16% | 0.02% | -59.3% | Q3 2024 | |
| $990K | 0.15% | 0.00% | Not reported | Q4 2024 | |
| $979K | 0.15% | 0.01% | Not reported | Q3 2025 | |
| $971K | 0.15% | 0.00% | New | Q1 2026 | |
| $925K | 0.14% | Not reported | +1.3% | Q3 2025 | |
| $891K | 0.14% | 0.00% | Not reported | Q2 2025 | |
| $881K | 0.14% | 0.02% | -44.8% | Q4 2025 | |
| $866K | 0.14% | 0.21% | New | Q1 2026 | |
| $851K | 0.13% | 0.00% | Not reported | Q1 2020 | |
| $847K | 0.13% | Not reported | Not reported | Q2 2018 | |
| $836K | 0.13% | Not reported | +7.8% | Q1 2022 | |
| $708K | 0.11% | 0.00% | New | Q1 2026 | |
| CIGTLSChart Industries Inc | $641K | 0.10% | 0.01% | +72.2% | Q3 2025 |
| $638K | 0.10% | 0.00% | New | Q1 2026 | |
| $635K | 0.10% | 0.01% | New | Q1 2026 | |
| $612K | 0.10% | 0.00% | +32.7% | Q2 2022 | |
| HHOLXHologic Inc | $605K | 0.09% | 0.00% | +81.8% | Q3 2025 |
| ATFOLDAmicus Therapeutics, Inc. | $594K | 0.09% | 0.01% | +245.4% | Q4 2025 |
| Q4 2025Reported Feb 17, 2026186 positions | |||||
| $45.1M | 7.11% | 0.16% | -19.9% | Q1 2024 | |
| ETESPREsperion Therapeutics, Inc. | $16.3M | 2.56% | 1.84% | -34.2% | Q1 2025 |
| $15.9M | 2.51% | 0.05% | -1.0% | Q2 2025 | |
| $15.9M | 2.51% | Not reported | Not reported | Q2 2025 | |
| $14.2M | 2.23% | 8.48% | Not reported | Q4 2021 | |
| $13.4M | 2.11% | 0.09% | -15.0% | Q2 2025 | |
| $8.72M | 1.37% | Not reported | +0.9% | Q1 2019 | |
| $4.44M | 0.70% | 0.23% | -33.1% | Q4 2020 | |
| $2.83M | 0.45% | 0.10% | -14.2% | Q1 2024 | |
| $2.52M | 0.40% | 0.00% | +92.8% | Q1 2019 | |
| WFWBSWebster Financial Corp | $2.38M | 0.38% | 0.02% | +548.1% | Q3 2024 |
| $2.36M | 0.37% | 0.04% | +61.2% | Q1 2022 | |
| $2.34M | 0.37% | 0.04% | Not reported | Q3 2024 | |
| $2.31M | 0.36% | 0.02% | New | Q4 2025 | |
| $2.31M | 0.36% | 0.01% | +0.1% | Q3 2025 | |
| $2.28M | 0.36% | 0.01% | +5877.4% | Q3 2024 | |
| $2.12M | 0.33% | Not reported | Not reported | Q4 2022 | |
| $1.99M | 0.31% | 0.04% | New | Q4 2025 | |
| $1.98M | 0.31% | 0.18% | Not reported | Q3 2025 | |
| $1.98M | 0.31% | 0.10% | +6288.9% | Q2 2025 | |
| $1.79M | 0.28% | 0.03% | +6000.0% | Q1 2020 | |
| $1.74M | 0.27% | 0.08% | +294.1% | Q1 2024 | |
| $1.48M | 0.23% | Not reported | Not reported | Q1 2025 | |
| $1.11M | 0.18% | 0.00% | +0.4% | Q4 2024 | |
| $1.08M | 0.17% | 0.00% | Not reported | Q2 2025 | |
| $1.04M | 0.16% | Not reported | +2.0% | Q3 2025 | |
| $1.02M | 0.16% | 0.20% | +84.2% | Q2 2025 | |
| $993K | 0.16% | Not reported | Not reported | Q2 2018 | |
| $945K | 0.15% | 0.00% | +3.3% | Q3 2022 | |
| SHSHCOSoho House & Co Inc. | $887K | 0.14% | 0.05% | +130.8% | Q3 2025 |
| $811K | 0.13% | 0.01% | Not reported | Q3 2025 | |
| $798K | 0.13% | 0.01% | Not reported | Q1 2025 | |
| $794K | 0.13% | Not reported | +8.1% | Q1 2022 | |
| $717K | 0.11% | Not reported | -47.5% | Q2 2022 | |
| $677K | 0.11% | 0.00% | +300.0% | Q3 2025 | |
| $668K | 0.11% | 0.00% | New | Q4 2025 | |
| $653K | 0.10% | 0.00% | New | Q4 2025 | |
| $619K | 0.10% | 0.02% | New | Q4 2025 | |
| DDAYDayforce, Inc. | $574K | 0.09% | 0.01% | +492.9% | Q3 2025 |
| $562K | 0.09% | 0.00% | New | Q4 2025 | |
| $551K | 0.09% | 0.02% | Not reported | Q3 2025 | |
| $526K | 0.08% | 0.00% | Not reported | Q3 2025 | |
| $497K | 0.08% | Not reported | -27.5% | Q3 2025 | |
| SAALSumisho Air Lease Corporation | $490K | 0.08% | 0.01% | +723.5% | Q3 2025 |
| $484K | 0.08% | 0.00% | Not reported | Q2 2022 | |
| $454K | 0.07% | 0.03% | Not reported | Q3 2025 | |
| $443K | 0.07% | Not reported | New | Q4 2025 | |
| $428K | 0.07% | 0.02% | +852.2% | Q4 2024 | |
| HHIHillenbrand, Inc. | $425K | 0.07% | 0.02% | New | Q4 2025 |
| COCIOCity Office REIT, Inc. | $410K | 0.06% | 0.15% | +39.1% | Q3 2025 |
| Q3 2025Reported Nov 14, 2025169 positions | |||||
| $43.1M | 7.28% | 2.20% | -3.3% | Q1 2024 | |
| $43.1M | 7.27% | 0.84% | New | Q3 2025 | |
| ETESPREsperion Therapeutics, Inc. | $17.7M | 2.98% | 3.31% | Not reported | Q1 2025 |
| $14.8M | 2.49% | 0.92% | +97.4% | Q2 2019 | |
| $14.3M | 2.41% | Not reported | New | Q3 2025 | |
| $14M | 2.36% | 8.48% | -12.9% | Q4 2021 | |
| $10.6M | 1.79% | 0.05% | Not reported | Q2 2025 | |
| $10.5M | 1.77% | Not reported | +307.3% | Q2 2025 | |
| $10.4M | 1.76% | 0.13% | Not reported | Q2 2025 | |
| $8.95M | 1.51% | Not reported | +1.1% | Q1 2019 | |
| $8.91M | 1.50% | 0.34% | Not reported | Q4 2020 | |
| $6.95M | 1.17% | 2.18% | -31.1% | Q1 2023 | |
| $2.45M | 0.41% | 0.02% | +9632.3% | Q2 2025 | |
| $2.36M | 0.40% | 0.12% | -3.9% | Q1 2024 | |
| $2.11M | 0.36% | Not reported | +29.5% | Q4 2022 | |
| $2.1M | 0.35% | 0.01% | New | Q3 2025 | |
| $1.99M | 0.34% | 0.04% | Not reported | Q3 2024 | |
| $1.96M | 0.33% | 0.25% | New | Q3 2025 | |
| $1.95M | 0.33% | 0.02% | +0.7% | Q3 2024 | |
| $1.89M | 0.32% | Not reported | -29.1% | Q1 2025 | |
| KKWKennedy-Wilson Holdings, Inc. | $1.49M | 0.25% | 0.13% | -32.2% | Q2 2018 |
| $1.43M | 0.24% | 0.03% | +1273.3% | Q1 2022 | |
| $1.33M | 0.22% | 0.00% | -30.4% | Q1 2019 | |
| $1.2M | 0.20% | Not reported | -51.8% | Q2 2022 | |
| $1.01M | 0.17% | Not reported | New | Q3 2025 | |
| $984K | 0.17% | 0.00% | Not reported | Q4 2024 | |
| $932K | 0.16% | 0.00% | Not reported | Q2 2025 | |
| $922K | 0.16% | 0.00% | Not reported | Q3 2022 | |
| $773K | 0.13% | 0.01% | New | Q3 2025 | |
| $771K | 0.13% | 0.09% | New | Q3 2025 | |
| $758K | 0.13% | 0.01% | Not reported | Q1 2025 | |
| $749K | 0.13% | Not reported | +17.3% | Q1 2022 | |
| $681K | 0.11% | Not reported | New | Q3 2025 | |
| $632K | 0.11% | 0.16% | New | Q3 2025 | |
| $631K | 0.11% | Not reported | Not reported | Q4 2024 | |
| $610K | 0.10% | Not reported | +362.6% | Q2 2025 | |
| $567K | 0.10% | Not reported | -12.2% | Q2 2022 | |
| $532K | 0.09% | Not reported | New | Q3 2025 | |
| $527K | 0.09% | 0.00% | New | Q3 2025 | |
| $523K | 0.09% | 0.02% | New | Q3 2025 | |
| $506K | 0.09% | 0.02% | -75.1% | Q1 2024 | |
| $494K | 0.08% | 0.01% | New | Q3 2025 | |
| CBCOOPCooperative Bankshares Inc | $443K | 0.07% | Not reported | New | Q3 2025 |
| VPVRNAVerona Pharma plc | $416K | 0.07% | 0.00% | New | Q3 2025 |
| VVMEOVimeo, Inc. | $411K | 0.07% | Not reported | Not reported | Q2 2021 |
| CIGTLSChart Industries Inc | $400K | 0.07% | 0.00% | New | Q3 2025 |
| SHSHCOSoho House & Co Inc. | $380K | 0.06% | 0.02% | New | Q3 2025 |
| $379K | 0.06% | 0.01% | New | Q3 2025 | |
| $377K | 0.06% | Not reported | Not reported | Q2 2025 | |
| $359K | 0.06% | 0.03% | New | Q3 2025 | |
Premium opens every quarter this fund has filed